The company is increasing its expected reported sales to a new range of $3.6B-$3.7B from $3.5B-$3.6B due to changes in foreign exchange rates. This outlook reflects the current state of tariffs and trade policy. FY25 consensus $3.57B.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- XRAY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Dentsply Sirona price target lowered to $16 from $20 at Piper Sandler
- Dentsply Sirona price target lowered to $16 from $18 at Mizuho
- Dentsply Sirona downgraded to Equal Weight at Morgan Stanley
- Dentsply Sirona downgraded to Equal Weight from Overweight at Morgan Stanley
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue